Zinc Acetate Dihydrate Tablet-Associated Gastritis Occurring in a Post-Hematopoietic Stem Cell Transplant Recipient.
Iwamuro MasayaTakehiro TanakaAkifumi MatsumuraSeiji KawanoYoshiro KawaharaHiroyuki OkadaPublished in: Case reports in gastrointestinal medicine (2022)
A 65-year-old Japanese woman underwent umbilical cord blood transplantation for acute myeloid leukemia. Zinc acetate dihydrate tablets were administered for hypozincemia after transplantation, and vomiting and appetite loss occurred soon thereafter. Esophagogastroduodenoscopy revealed mucosal redness, erosion, white coat adhesion, and ulcers. Although graft-versus-host disease, intestinal transplant-associated microangiopathy, and cytomegalovirus infection were considered as possible causes, we diagnosed the patient with zinc acetate dihydrate tablet-associated gastric mucosal alterations based on the endoscopic features. This case reinforces the notion that medication-associated gastric lesions should be suspected in patients taking zinc acetate dihydrate tablets.
Keyphrases
- oxide nanoparticles
- umbilical cord
- acute myeloid leukemia
- mesenchymal stem cells
- hematopoietic stem cell
- end stage renal disease
- ejection fraction
- newly diagnosed
- case report
- chronic kidney disease
- helicobacter pylori
- peritoneal dialysis
- healthcare
- prognostic factors
- cell therapy
- weight loss
- stem cells
- pseudomonas aeruginosa
- emergency department
- body weight
- biofilm formation
- staphylococcus aureus
- drug induced